Want to continue viewing company data?

Sign up for exclusive competitive intelligence.
Company Data Subscription $329 per month (billed Annually)
Signup to View Free Sample

View up-to-date information on Xencor Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Find out more

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
November 21, 2021 Zenas BioPharma Acquires Rights to Obexelimab from Xencor Asset Transaction Zenas BioPharma (USA) LLC Xencor Inc
November 12, 2021 Xencor Raises USD25 Million in Equity Financing Equity Offering - Xencor Inc
October 01, 2021 Janssen Biotech to Enter into Licensing Agreement with Xencor to Advance Plamotamab and XmAb CD28 Bispecific Antibody Licensing Agreement Janssen Biotech Inc Xencor Inc
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you subscribe Explore the latest deals, partnerships, mergers & acquisitions when you subscribe Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer